News from Zyme and the companies we work with.

October 18, 17

SYGNIS AG announces completion of relocation of its Innova Biosciences unit to allow for expansion

Move forms part of integration into SYGNIS Group Madrid, Spain and Heidelberg, Germany, 18 October 2017 – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard) today announced the completion of the relocation of its subsidiary company, Innova Biosciences, into the … Continue reading

October 17, 17

TTP Plc and Sphere Fluidics introduce Cyto-Mine Single Cell Analysis System

A novel and disruptive analysis and monoclonal assurance system for drug discovery and development Cambridge, UK, 17 October 2017: TTP Plc (TTP), a leading independent technology and product development company, and Sphere Fluidics, which provides single cell analysis systems underpinned … Continue reading

October 17, 17

Desktop Genetics introduces new series of customizable CRISPR libraries

DESKGEN Series Libraries are designed and manufactured using the latest CRISPR gene editing techniques and artificial intelligence to deliver a tailored end-to-end solution London, UK – 17 October 2017 – Desktop Genetics Ltd (“the Company”), a company revolutionizing the way … Continue reading

October 11, 17

Irvine Scientific Introduces Arctic Sperm Cryopreservation Medium

Modern formula improves post-thaw performance and reduces costs of freezing sperm  SANTA ANA, California – October 11th, 2017: Irvine Scientific, a world leader in the development and manufacture of cell culture media and Assisted Reproductive Technologies (ART), today announced the … Continue reading

October 11, 17

Gyros Protein Technologies signs distribution agreement with Euro Diagnostica

Gyros Protein Technologies becomes distributor of iLite cell-based reporter gene assays for drug development Uppsala and Malmö, Sweden, 11 October 2017: Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, today … Continue reading

October 11, 17

Concept Life Sciences appoints Marc Princivalle as Group Head of Toxicology

Appointment supports growth of the Company and expansion of expertise in integrated drug discovery and development Manchester, UK, 11 October 2017: Concept Life Sciences (Concept), the integrated drug discovery, development and analytical services company, today announced it has appointed Marc … Continue reading

October 10, 17

Optibrium Joins EUR 40 Million eTRANSAFE project

Prestigious line-up of pharma, academia and SMEs aim to improve security in drug development process CAMBRIDGE, UK, 10 October 2017 – Optibrium™, a developer of software for small molecule drug discovery, today announced that it will join the Enhancing Translational … Continue reading

October 5, 17

Avacta initiates gene therapy research collaboration with FIT Biotech Oy

Collaboration to assess the benefits of combining Affimer technology with FIT Biotech’s gtGTU platform Wetherby and Cambridge, UK, 05 October 2017:   Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce it has initiated a research collaboration … Continue reading

October 4, 17

Avacta Group plc – Preliminary Results for the Year Ending 31 July 2017

Preliminary Results for the Year Ending 31 July 2017  Further significant progress in the Affimer therapeutics programmes  Commercial traction for Affimer reagents building and multiple licenses agreed  Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased … Continue reading

October 4, 17

Desktop Genetics opens £1.5 million investment round via SyndicateRoom to support growth

Leader in artificial intelligence for CRISPR genome editing technology seeks funding to build on successful research programmes and commercialise new products London, UK – 4 October 2017 – Desktop Genetics Ltd (DTG), a software company revolutionising the way biologists use CRISPR genome … Continue reading